Centauri Therapeutics is an immunotherapy company focused on infectious diseases.  Centauri’s proprietary Alphamerâ„¢ platform is protected by a portfolio of patents and enables the discovery and development of multiple candidate molecules.  All projects harness a powerful and clinically validated immune mechanism which redirects naturally existing antibodies to treat life-threatening diseases.